This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Briscoe Law Firm Investigates Genoptix, Inc. On Behalf Of Shareholders For Possible Breaches Of Fiduciary Duties By Its Officers And Directors

The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor LLP are investigating potential legal claims against the Board of Directors of Genoptix, Inc (“Genoptix” or “GXDX”) (NASDAQ: GXDX) during the period of July 31, 2009 and June 15, 2010.

It has been alleged in a recently filed complaint that during the period of July 31, 2009 through June 15, 2010 (the “class period”) Genoptix and certain of its executive officers and directors engaged in violations of the Securities Exchange Act of 1934. More specifically, the complaint alleges that Genoptix failed to disclose and misrepresented the following material adverse facts which were allegedly known to the defendants or recklessly disregarded by them: (1) that the company's current business model was unsustainable; (2) that due to known trends and uncertainties, including increased competition and increased managed care pressures, Genoptix would be unable to grow and would have difficulty maintaining its current client base; (3) that the reconfiguration of Genoptix's sales force had severely impacted its ability to grow revenue; (4) that Genoptix lacked adequate internal controls; and (5) that, as a result of the foregoing, the defendants lacked any reasonable basis for their positive statements about Genoptix's growth and prospects.

Moreover, it has further been alleged that during the class period, certain of the company's top executives and/or directors sold approximately 172,000 Genoptix shares at artificially inflated prices for proceeds of approximately $5.8 million.

If you currently own or purchased Genoptix/GXDX shares and would like additional information regarding this investigation, or if you have information regarding the allegations against the company, please contact Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877) 397-5991, or via email at There is no cost or fee to you.

The Briscoe Law Firm is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs